Format

Send to

Choose Destination
J Infect Dis. 2017 Jul 1;216(1):135-145. doi: 10.1093/infdis/jix252.

Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Yao Y1,2,3, Lai R1,2,3, Afkhami S1,2,3, Haddadi S1,2,3, Zganiacz A1,2,3, Vahedi F1,2,3, Ashkar AA1,2,3, Kaushic C1,2,3, Jeyanathan M1,2,3, Xing Z1,2,3.

Author information

1
McMaster Immunology Research Centre.
2
Department of Pathology & Molecular Medicine.
3
Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.

Abstract

Background:

The translation of preclinically promising novel tuberculosis vaccines to ultimate human applications has been challenged by the lack of animal models with an immune system equivalent to the human immune system in its genetic diversity and level of susceptibility to tuberculosis.

Methods:

We have developed a humanized mice (Hu-mice) tuberculosis model system to investigate the clinical relevance of a novel virus-vectored (VV) tuberculosis vaccine administered via respiratory mucosal or parenteral route.

Results:

We find that VV vaccine activates T cells in Hu-mice as it does in human vaccinees. The respiratory mucosal route for delivery of VV vaccine in Hu-mice, but not the parenteral route, significantly reduces the humanlike lung tuberculosis outcomes in a human T-cell-dependent manner.

Conclusions:

Our results suggest that the Hu-mouse can be used to predict the protective efficacy of novel tuberculosis vaccines/strategies before they proceed to large, expensive human trials. This new vaccine testing system will facilitate the global pace of clinical tuberculosis vaccine development.

KEYWORDS:

Tuberculosis; humanized mice; respiratory mucosal immunization; viral-vectored vaccines

PMID:
28531291
PMCID:
PMC5853534
DOI:
10.1093/infdis/jix252
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center